216 related articles for article (PubMed ID: 17361849)
1. Leishmania panamensis transmission in the domestic environment: the results of a prospective epidemiological survey in Santander, Colombia.
Muñoz G; Davies CR
Biomedica; 2006 Oct; 26 Suppl 1():131-44. PubMed ID: 17361849
[TBL] [Abstract][Full Text] [Related]
2. [Presence of infected vectors of Leishmania (V.) panamensis within dwellings in two endemic foci in the foothill of the middle Magdalena valley, western Boyacá, Colombia].
Santamaría E; Ponce N; Zipa Y; Ferro C
Biomedica; 2006 Oct; 26 Suppl 1():82-94. PubMed ID: 17361845
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous leishmaniasis imported from Colombia to Northcentral Venezuela: implications for travel advice.
Delgado O; Silva S; Coraspe V; Rivas MA; Rodriguez-Morales AJ; Navarro P; Franco-Paredes C
Travel Med Infect Dis; 2008 Nov; 6(6):376-9. PubMed ID: 18984484
[TBL] [Abstract][Full Text] [Related]
4. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics.
Osorio LE; Castillo CM; Ochoa MT
Am J Trop Med Hyg; 1998 Jul; 59(1):49-52. PubMed ID: 9684627
[TBL] [Abstract][Full Text] [Related]
5. A multifaceted intervention to prevent American cutaneous leishmaniasis in Colombia: results of a group-randomized trial.
Rojas CA; Weigle KA; Tovar R; Morales AL; Alexander B
Biomedica; 2006 Oct; 26 Suppl 1():152-66. PubMed ID: 17361851
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and tolerance of pentamidine for treatment of cutaneous leishmaniasis caused by por L. (V) panamensis in Colombia].
Robledo SM; Puerta JA; Muñoz DL; Guardo M; Vélez ID
Biomedica; 2006 Oct; 26 Suppl 1():188-93. PubMed ID: 17361854
[TBL] [Abstract][Full Text] [Related]
7. Leishmania braziliensis from the Pacific coast region of Colombia: foci of transmission, clinical spectrum and isoenzyme phenotypes.
Weigle KA; Saravia NG; de Dávalos M; Moreno LH; D'Alessandro A
Am J Trop Med Hyg; 1986 Jul; 35(4):722-31. PubMed ID: 3728793
[TBL] [Abstract][Full Text] [Related]
8. Leishmaniasis recidiva cutis due to Leishmania (Viannia) panamensis in subtropical Ecuador: isoenzymatic characterization.
Calvopina M; Uezato H; Gomez EA; Korenaga M; Nonaka S; Hashiguchi Y
Int J Dermatol; 2006 Feb; 45(2):116-20. PubMed ID: 16445499
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of cutaneous and disseminated cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Paraty, Rio de Janeiro.
Vieira-Gonçalves R; Pirmez C; Jorge ME; Souza WJ; Oliveira MP; Rutowitsch MS; Da-Cruz AM
Int J Dermatol; 2008 Sep; 47(9):926-32. PubMed ID: 18937655
[TBL] [Abstract][Full Text] [Related]
10. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiological features of cutaneous leishmaniasis americana in an endemic region of the state of Bahia, Brazil. I. Human leishmaniasis].
Barretto AC; Cuba CA; Marsden PD; Vexanat JA; De Belder M
Bol Oficina Sanit Panam; 1981 May; 90(5):415-24. PubMed ID: 6456727
[No Abstract] [Full Text] [Related]
12. [The basic health plan's impact on preventing cutaneous leishmaniasis in rural areas of Santander, Colombia].
Rodríguez-Villamizar LA; Orozco-Vargas LC; Muñoz-Mantilla G
Rev Salud Publica (Bogota); 2006 May; 8 Suppl 1():116-28. PubMed ID: 16925126
[TBL] [Abstract][Full Text] [Related]
13. Leishmaniasis caused by Leishmania (Viannia) guyanensis in north-central Pacific region of Ecuador: A clinico-epidemiological feature.
Gomez EA; Kato H; Torres-Romero EX; Velez LN; Villegas NV; Martillo VP; Zambrano FC; Kubo M; Hashiguchi K; Hashiguchi Y
Acta Trop; 2018 Sep; 185():204-211. PubMed ID: 29852129
[TBL] [Abstract][Full Text] [Related]
14. [Mucocutaneous leishmaniasis in Panama. Etiologic agent, epidemiologic and clinical aspects].
Sáenz RE; Paz HM; de Rodriguez GC; de Vásquez AM; Mata RE; Johnson CM
Rev Med Panama; 1989 Jan; 14(1):6-15. PubMed ID: 2727332
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for mucosal manifestation of American cutaneous leishmaniasis.
Machado-Coelho GL; Caiaffa WT; Genaro O; Magalhães PA; Mayrink W
Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):55-61. PubMed ID: 15550262
[TBL] [Abstract][Full Text] [Related]
16. Re-establishment of cutaneous leishmaniasis after cessation of anti-malaria spraying.
Seyedi-Rashti MA; Nadim A
Trop Geogr Med; 1975 Mar; 27(1):79-82. PubMed ID: 1094645
[TBL] [Abstract][Full Text] [Related]
17. [Species of Lutzomyia (Psychodidae, Phlebotominae) in endemic cutaneous and visceral leishmaniasis foci of the department of Santander, in the eastern range of the Colombian Andes].
Sandoval CM; Gutiérrez R; Cárdenas R; Ferro C
Biomedica; 2006 Oct; 26 Suppl 1():218-27. PubMed ID: 17361857
[TBL] [Abstract][Full Text] [Related]
18. Intraspecific heterogeneity in the mini-exon gene localization of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis from Colombia.
Pacheco RS; Fernandes O; Salinas G; Segura I; Momen H; Degrave W; Saravia NG; Campbell DA
J Parasitol; 2000 Dec; 86(6):1250-3. PubMed ID: 11191900
[TBL] [Abstract][Full Text] [Related]
19. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
Schenkel K; Rijal S; Koirala S; Koirala S; Vanlerberghe V; Van der Stuyft P; Gramiccia M; Boelaert M
Trop Med Int Health; 2006 Dec; 11(12):1792-9. PubMed ID: 17176343
[TBL] [Abstract][Full Text] [Related]
20. [Mucocutaneous leishmaniasis in Brazilian Amazonia].
Camuset G; Remy V; Hansmann Y; Christmann D; Gomes de Albuquerque C; Sena Casseb GA
Med Mal Infect; 2007 Jun; 37(6):343-6. PubMed ID: 17512150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
